ASCO 2023
2-6 June 2023, McCormick Place, Booth # 4113, Chicago, IL
Thank you for speaking with the ICON team at ASCO 2023
We invite you to explore the resources we have assembled below to demonstrate how we can support your Oncology clinical development programme.
Contact us for more information or to arrange a meeting with our Oncology experts.
Brochures and factsheets:
Oncology Clinical Development
The most comprehensive span of Oncology clinical development services — delivered seamlessly
Cell and Gene Therapy trials
Delivering differently.
Biotech Services
Transformative therapies start with transformative approaches.
Paediatrics Clinical Develpment
Driving paediatric clinical research forward and protecting kids through research—not from it
Decentralised Clinical Trials
Delivering quality data quicker for faster time to market.
Acellacare in Home Services
The global clinical research network increasing patient recruitment with a patient centric approach.
One Search
Improving site selection and study start-up
FIRECREST
Site Performance Ignited
Early Phase Oncology
ICON offers a flexible Early Phase model focused on optimizing study design, faster first patient, faster enrollment.
Oncology Laboratory Services
ICON Laboratories’ extensive testing capabilities, combined with our clinical research experience and scientific expertise.
Specialty Lab Services for CGT
Deep expertise across a broad spectrum of testing techniques.
Accelerated Early Clinical Manufacturing in Oncology
Fully integrated services in drug product development and manufacturing.
Medical Imaging Solutions
ICON Medical Imaging provides end-to-end integrated solutions based on the science of imaging biomarkers
Commercialisation & Outcomes Solutions
ICON is a world leader in commercialisation and outcomes services
Medical Imaging Oncology Services
Transforming images into information. Turning information into therapies.
Case studies:
Improving early phase oncology clinical trial design using Bayesian based BOIN and BOP2 designs
Leveraging Immuno-Oncology real world data to amend non-small cell lung cancer study design
Successful adaptation to complex dose escalation within a large master protocol basket design across Immuno-Oncology co-therapies
Meeting unique needs in Cell and Gene Therapy trials with accelerated timelines
Successes in phase 2 autologous cellular therapy Oncology programme
Phase 3 Multiple Myeloma Trial
Expedited study start-up for central radiology and clinical data review.
Whitepapers and on-demand webinars:
Mainstreaming Cell & Gene Therapies
Development, manufacturing, regulation and market access.
The RACE for Children Act
How industry can accelerate readiness through collaboration with patient organisations.
Webinar: Best practices for laboratory solutions relating to cell and gene therapy clinical trials
Supporting the unique requirements with specialty molecular and flow cytometry
Diversity and inclusion in clinical trials
Paving the way for diversity and inclusion in clinical trials: establishing a platform for improvement.